Composition of Mytolac®
MYTOLAC® CONTAINS THE SAME LANREOTIDE MOLECULE AS SOMATULINE1,2
MYTOLAC® is a synthetic analogue of natural somatostatin.1
| Route of administration | Dosage form/strength/composition | Non-medicinal ingredients |
|---|---|---|
| Deep subcutaneous injection | Extended-release solution 60 mg, 90 mg, 120 mg lanreotide (as lanreotide acetate) per unit (syringe) | Acetic acid, water for injection |
Mytolac® DEMONSTRATED BIOEQUIVALENCE TO SOMATULINE. BIOEQUIVALENCE
WAS INFERRED FROM SURROGATE IN VITRO DATA IN
THE Sameness STUDY.3
